Semi-infectious particles contribute substantially to influenza virus within-host dynamics when infection is dominated by spatial structure

Influenza is an ribonucleic acid virus with a genome that comprises eight segments. Experiments show that the vast majority of virions fail to express one or more gene segments and thus cannot cause a productive infection on their own. These particles, called semi-infectious particles (SIPs), can induce virion production through complementation when multiple SIPs are present in an infected cell. Previous within-host influenza models did not explicitly consider SIPs and largely ignore the potential effects of coinfection during virus infection. Here, we constructed and analyzed two distinct models explicitly keeping track of SIPs and coinfection: one without spatial structure and the other implicitly considering spatial structure. While the model without spatial structure fails to reproduce key aspects of within-host influenza virus dynamics, we found that the model implicitly considering the spatial structure of the infection process makes predictions that are consistent with biological observations, highlighting the crucial role that spatial structure plays during an influenza infection. This model predicts two phases of viral growth prior to the viral peak: a first phase driven by fully infectious particles at the initiation of infection followed by a second phase largely driven by coinfections of fully infectious particles and SIPs. Fitting this model to two sets of data, we show that SIPs can contribute substantially to viral load during infection. Overall, the model provides a new interpretation of the in vivo exponential viral growth observed in experiments and a mechanistic explanation for why the production of large numbers of SIPs does not strongly impede viral growth. Being simple and predictive, our model framework serves as a useful tool to understand coinfection dynamics in spatially structured acute viral infections.

[1]  L. Weinberger,et al.  Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance , 2021, Cell.

[2]  R. Ke,et al.  Autocrine and paracrine interferon signalling as ‘ring vaccination’ and ‘contact tracing’ strategies to suppress virus infection in a host , 2021, Proceedings of the Royal Society B.

[3]  R. Ke,et al.  Single cell heterogeneity in influenza A virus gene expression shapes the innate antiviral response to infection , 2020, PLoS pathogens.

[4]  K. Koelle,et al.  Cellular co-infection can modulate the efficiency of influenza A virus production and shape the interferon response , 2019, bioRxiv.

[5]  Christian Quirouette,et al.  A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract , 2019, PLoS Comput. Biol..

[6]  N. Jacobs,et al.  Incomplete influenza A virus genomes occur frequently but are readily complemented during localized viral spread , 2019, Nature Communications.

[7]  H. Dai,et al.  Principles of Effective and Robust Innate Immune Response to Viral Infections: A Multiplex Network Analysis , 2019, Front. Immunol..

[8]  M. Vignuzzi,et al.  Defective viral genomes are key drivers of the virus–host interaction , 2019, Nature Microbiology.

[9]  U. Reichl,et al.  A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome , 2018, Journal of Virology.

[10]  K. Koelle,et al.  Causes and Consequences of Spatial Within-Host Viral Spread , 2018, Viruses.

[11]  J. Bloom,et al.  Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity , 2019, Journal of Virology.

[12]  A. Perelson,et al.  Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence , 2018, Proceedings of the National Academy of Sciences.

[13]  Katia Koelle,et al.  Within-host infectious disease models accommodating cellular coinfection, with an application to influenza† , 2018, bioRxiv.

[14]  I. Amit,et al.  Dissection of Influenza Infection In Vivo by Single-Cell RNA Sequencing , 2018, Cell Systems.

[15]  C. Brooke,et al.  Influenza A Virus Superinfection Potential Is Regulated by Viral Genomic Heterogeneity , 2018, mBio.

[16]  David J. Moquin,et al.  Influenza Virus Infection Model With Density Dependence Supports Biphasic Viral Decay , 2018, bioRxiv.

[17]  J. Bloom,et al.  Extreme heterogeneity of influenza virus infection in single cells , 2017, bioRxiv.

[18]  C. Brooke Population Diversity and Collective Interactions during Influenza Virus Infection , 2017, Journal of Virology.

[19]  D. Dou,et al.  Analysis of IAV Replication and Co-infection Dynamics by a Versatile RNA Viral Genome Labeling Method. , 2017, Cell reports.

[20]  Judith M. Fonville,et al.  Influenza Virus Reassortment Is Enhanced by Semi-infectious Particles but Can Be Suppressed by Defective Interfering Particles , 2015, PLoS pathogens.

[21]  C. Beauchemin,et al.  Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility , 2015, PloS one.

[22]  H. Kitano,et al.  Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies , 2015, Nature Communications.

[23]  J. Yewdell,et al.  Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility , 2014, Proceedings of the National Academy of Sciences.

[24]  Alan S. Perelson,et al.  Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study , 2014, PLoS Comput. Biol..

[25]  N. Dimmock,et al.  Defective Interfering Influenza Virus RNAs: Time To Reevaluate Their Clinical Potential as Broad-Spectrum Antivirals? , 2014, Journal of Virology.

[26]  C. Brooke,et al.  Biological activities of 'noninfectious' influenza A virus particles. , 2014, Future virology.

[27]  A. Osterhaus,et al.  Genomewide Analysis of Reassortment and Evolution of Human Influenza A(H3N2) Viruses Circulating between 1968 and 2011 , 2013, Journal of Virology.

[28]  E. Nsoesie,et al.  A systematic review of studies on forecasting the dynamics of influenza outbreaks , 2013, Influenza and other respiratory viruses.

[29]  D. Poole,et al.  Highly Sensitive Real-Time In Vivo Imaging of an Influenza Reporter Virus Reveals Dynamics of Replication and Spread , 2013, Journal of Virology.

[30]  Weixu Meng,et al.  Visualizing influenza virus infection in living mice , 2013, Nature Communications.

[31]  John Steel,et al.  Influenza Virus Reassortment Occurs with High Frequency in the Absence of Segment Mismatch , 2013, PLoS pathogens.

[32]  N. Heaton,et al.  In Vivo Bioluminescent Imaging of Influenza A Virus Infection and Characterization of Novel Cross-Protective Monoclonal Antibodies , 2013, Journal of Virology.

[33]  J. Yewdell,et al.  Most Influenza A Virions Fail To Express at Least One Essential Viral Protein , 2013, Journal of Virology.

[34]  Albert D. M. E. Osterhaus,et al.  Comparison of Temporal and Spatial Dynamics of Seasonal H3N2, Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Virus Infections in Ferrets , 2012, PloS one.

[35]  Guy Boivin,et al.  The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets , 2012, Journal of Virology.

[36]  A. Perelson,et al.  Combination antiviral therapy for influenza: predictions from modeling of human infections. , 2012, The Journal of infectious diseases.

[37]  Alan S. Perelson,et al.  Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses , 2012, PLoS Comput. Biol..

[38]  A. Perelson,et al.  Influenza A virus infection kinetics: quantitative data and models , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[39]  J. Taubenberger,et al.  Influenza virus evolution, host adaptation, and pandemic formation. , 2010, Cell host & microbe.

[40]  Alan S. Perelson,et al.  Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus , 2010, Journal of Virology.

[41]  Ann Cullinane,et al.  Dynamics of Influenza Virus Infection and Pathology , 2010, Journal of Virology.

[42]  U Reichl,et al.  Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling. , 2009, Vaccine.

[43]  Ruy M Ribeiro,et al.  Modeling amantadine treatment of influenza A virus in vitro. , 2008, Journal of theoretical biology.

[44]  Ann Cullinane,et al.  Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. , 2007, Vaccine.

[45]  C. Bridges,et al.  The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.

[46]  R. D. de Boer,et al.  Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus , 2007, Journal of Virology.

[47]  A. Perelson,et al.  Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.

[48]  J. Taubenberger,et al.  1918 Influenza: the Mother of All Pandemics , 2006, Emerging infectious diseases.

[49]  Bryan T Grenfell,et al.  Whole-Genome Analysis of Human Influenza A Virus Reveals Multiple Persistent Lineages and Reassortment among Recent H3N2 Viruses , 2005, PLoS biology.

[50]  Alan S Perelson,et al.  HIV dynamics with multiple infections of target cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  H. Klenk,et al.  Human and avian influenza viruses target different cell types in cultures of human airway epithelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Chanock,et al.  Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. , 1980, Infection and immunity.

[53]  G. K. Hirst,et al.  Mechanism of influenza recombination. II. Virus aggregation and its effect on plaque formation by so-called noninfective virus. , 1973, Virology.